Common use of No Substitution Clause in Contracts

No Substitution. Provider and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal Investigator, CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination provisions below. 1.4.

No Substitution. Provider Institution and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator investigator without prior written authorization from Sponsor. Any replacement Principal Investigator principal investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal Investigatorprincipal investigator, Sponsor or CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination termination provisions below. 1.4.

No Substitution. Provider Institution and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writingamendment. In the event Sponsor does not approve a replacement Principal Investigator, CRO any contracting party or Sponsor may terminate this Agreement or with immediate effect. Sponsor and CRO per Sponsor’s request may acknowledge that Institution has right to terminate in accordance employment relationship with Principal Investigator and this will not be considered as breach of the Termination provisions belowAgreement. 1.4.

No Substitution. Provider and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writingwritten amendment to this Agreement. In the event Sponsor does not approve a replacement Principal Investigator, Sponsor or CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination provisions below. 1.4.

No Substitution. Provider Institution and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor/CRO. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor Sponsor/CRO does not approve a replacement Principal InvestigatorInvestigator and this dissaproval will not be unjutisfied, Sponsor or CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination provisions below. 1.4.

No Substitution. Provider Institution and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal InvestigatorInvestigator and this dissaproval will not be unjutisfied, Sponsor or CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination provisions below. 1.41.5.

No Substitution. Provider Institution and Principal Investigator may not reassign the conduct of the Trial Study to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal Investigator, Sponsor or CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination termination provisions below. 1.4.